EUVIMEDDescubrir EUVIMED
Crossref

Baicalin ameliorates high fat diet‐induced nonalcoholic fatty liver disease in mice via adenosine monophosphate‐activated protein kinase‐mediated regulation of SREBP1 /Nrf2/ NF‐κB signaling pathways

Yanxia Gao iD, Jingbo Liu, Zhili Hao, Na Sun, Jianhua Guo, Xiaozhong Zheng, Panpan Sun, Wei Yin, Kuohai Fan, Hongquan Li iD

Phytotherapy Research · 2023-06 · 37 (6) · 2405-2418

DOI: 10.1002/ptr.7762 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2023-02-08. Written by Yanxia Gao and 9 co-authors. Institution: Shanxi Key Lab for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, China. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease. Cited 24 times so far (Crossref); 64 references. Funded by: Project of Tai'an City Science and Technology Innovative Development of Shandong Province, Natural Science Foundation of Shandong Province, Key Research and Development Plan of Shanxi Province.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease around the world, imposing severe threats on human health. Unfortunately, no clinically approved drugs are available for use as yet. Baicalin (BA) is reported to have hepatoprotective effects, and it is not clear whether BA can treat NAFLD and how. Here, a high‐fat diet (HFD)‐induced NAFLD mouse model was established to explore the protective roles and mechanisms of BA against HFD‐induced NAFLD. Physiochemical results showed that BA exhibited significantly protective effects against HFD‐induced NAFLD in mice. Liver transcriptomic analysis revealed that BA attenuated HFD‐induced NAFLD via activating AMPK pathway, which was confirmed by the AMPK inhibitor Compound C. Additionally, the expression changes of AMPK downstream genes demonstrated that BA exerted ameliorative effects against NAFLD through AMPK‐mediated inhibition of SREBP1 and NF‐κB pathways, and activation of Nrf2 pathway. Taken together, our study reveals the protective roles of BA against HFD‐caused NAFLD through AMPK‐mediated modulation of SREBP1/Nrf2/NF‐κB pathways, suggesting that BA has potential drug development implications. Most importantly, our study creates a paradigm through the combination of molecular biology and bioinformatics for further studies of action mechanisms of biomolecules combating diseases.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsMiceAMP-Activated Protein KinasesDiet, High-FatLipid MetabolismLiverMice, Inbred C57BLNF-E2-Related Factor 2NF-kappa BSignal TransductionFlavonoids

Author keywords

AMPKBaicalinSREBP1/Nrf2/NF-κB pathwayshigh fat dietnonalcoholic fatty liver disease

Substances

AMP-Activated Protein KinasesNF-E2-Related Factor 2NF-kappa BbaicalinFlavonoids

Authors and institutions

  • Shanxi Key Lab for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu, China.
  • College of Life Science, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, China.
  • College of Biological and Brewing Engineering, Taishan University, Tai'an, China.
  • College of Veterinary Medicine, Jilin University, Changchun, China.
  • Department of Veterinary Pathobiology, Schubot Exotic Bird Health Center, Texas A&M University, College Station, Texas, USA.
  • Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.

ORCID profiles: Yanxia Gao, Hongquan Li

Funding

  • Project of Tai'an City Science and Technology Innovative Development of Shandong Province
  • Natural Science Foundation of Shandong Province
  • Key Research and Development Plan of Shanxi Province
  • Shanxi Provincial Key Research and Development Project

Cite

APA

Gao, Y., Liu, J., Hao, Z., Sun, N., Guo, J., Zheng, X., Sun, P., Yin, W., Fan, K., & Li, H. (2023). Baicalin ameliorates high fat diet‐induced nonalcoholic fatty liver disease in mice via adenosine monophosphate‐activated protein kinase‐mediated regulation of SREBP1 /Nrf2/ NF‐κB signaling pathways. Phytotherapy Research, 37(6), 2405-2418. https://doi.org/10.1002/ptr.7762

Vancouver

Gao Y, Liu J, Hao Z, Sun N, Guo J, Zheng X, et al. Baicalin ameliorates high fat diet‐induced nonalcoholic fatty liver disease in mice via adenosine monophosphate‐activated protein kinase‐mediated regulation of SREBP1 /Nrf2/ NF‐κB signaling pathways. Phytotherapy Research. 2023;37(6):2405-2418. doi:10.1002/ptr.7762

BibTeX
@article{Gao2023,
  author = {Gao, Yanxia and Liu, Jingbo and Hao, Zhili and Sun, Na and Guo, Jianhua and Zheng, Xiaozhong and Sun, Panpan and Yin, Wei and Fan, Kuohai and Li, Hongquan},
  title = {Baicalin ameliorates high fat diet‐induced nonalcoholic fatty liver disease in mice via adenosine monophosphate‐activated protein kinase‐mediated regulation of SREBP1 /Nrf2/ NF‐κB signaling pathways},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {6},
  pages = {2405--2418},
  doi = {10.1002/ptr.7762}
}
Start for free →